Posts

Posted on

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences

Believes Merger Agreement Significantly Undervalues Quanterix

RINCON, Puerto Rico–(BUSINESS WIRE)–
Kent Lake PR LLC (“Kent Lake”), a holder of 5.9% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), today highlighted its opposition to the Company’s proposed merger (the “Merger”) with Akoya Biosciences (“Akoya”) (NASDAQ: AKYA). Kent Lake has also issued an open letter to all Quanterix shareholders outlining how the Merger significantly undervalues the Company and its intention to take all necessary steps to vote against the deal.

The full text of the letter can be viewed here.

In its letter, Kent Lake details the following key reasons to vote against the Merger:

  • A Massive and Unjustifiable Valuation Disparity: The deal assigns Quanterix an enterprise value of only $42 million, while valuing the weaker Akoya business at $168 million despite Quanterix’s superior revenue, growth, and market opportunity.
  • A Bailout for Akoya at Quanterix Shareholders’ Expense: Akoya’s financial struggles would have forced it to seek external financing at a deep discount. Instead, Quanterix’s Board of Directors (the “Board”) is handing it a premium at the expense of its own investors.
  • A Major Risk to Quanterix’s Financial Strength: Post-merger, Quanterix’s cash runway shrinks from 6.5 years to just 2.5 years, dramatically increasing the likelihood of future dilutive equity raises.
  • A Distraction from Quanterix’s Biggest Growth Opportunity: The Company stands at a critical moment in its Alzheimer’s diagnostic expansion, requiring full focus on FDA approval, reimbursement, and commercialization – not the acquisition of a struggling peer.
  • Illusory Synergies with High Execution Risk: Akoya has already cut its workforce by 35%, leading to declining revenue. Additional cost reductions risk further destabilization rather than generating true operational efficiencies.

Ben Natter, Managing Member of Kent Lake, issued the following statement:

“The Merger terms are indefensible and would permanently impair QTRX shareholders while depleting nearly $100 million in net cash to bail out Akoya. We urge the Quanterix Board to abandon this misguided merger and explore alternative paths that we believe could deliver superior value, including refocusing on the Company’s promising organic growth opportunities as a standalone entity or pursuing a sale of Quanterix at a valuation exceeding $1 billion.

Kent Lake is prepared to take all necessary steps to mobilize shareholders to vote against the deal, including nominating directors to the Quanterix Board at the 2025 Annual Meeting. We look forward to communicating further with our fellow shareholders in the coming weeks.”

THIS IS NOT A SOLICITATION OF AUTHORITY TO VOTE YOUR PROXY. DO NOT SEND US YOUR PROXY CARD. KENT LAKE IS NOT ABLE TO VOTE YOUR PROXY, NOR DOES THIS COMMUNICATION CONTEMPLATE SUCH AN EVENT.

For media inquiries, please contact:

Ben Natter, 415-799-2720

[email protected]

KEYWORDS: Latin America Caribbean Puerto Rico

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Posted on

IIPR Investors Have Opportunity to Lead Innovative Industrial Properties, Inc. Securities Fraud Lawsuit

PR Newswire


NEW YORK
, Feb. 18, 2025 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Innovative Industrial Properties, Inc. (NYSE: IIPR) between February 27, 2024 and December 19, 2024, both dates inclusive (the “Class Period”), of the important March 18, 2025 lead plaintiff deadline.

So what: If you purchased IIPR securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the IIPR class action, go to https://rosenlegal.com/submit-form/?case_id=33890 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 18, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) IIPR was experiencing significant declines in rent and property-management fees in connection with certain customer leases; (2) the foregoing would likely impair IIPR’s ability to maintain FFO and revenue growth; (3) accordingly, IIPR’s leasing operations were less profitable than IIPR had represented to investors; and (4) as a result, IIPR’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the IIPR class action, go to https://rosenlegal.com/submit-form/?case_id=33890 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/iipr-investors-have-opportunity-to-lead-innovative-industrial-properties-inc-securities-fraud-lawsuit-302379148.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

James Hardie Building Products Inc. locks in a six-year agreement with David Weekley Homes

PR Newswire


The largest home siding company in North America announces a six-year relationship with one of the nation’s largest privately held home builders, David Weekley Homes.

 


CHICAGO
, Feb. 18, 2025 /PRNewswire/ — James Hardie Building Products Inc. (James Hardie), the North American leader in fiber cement home siding and exterior design solutions, proudly announces a six-year agreement with one of the nation’s largest privately held home builders, David Weekley Homes. Last year James Hardie was honored for the 16th time in 18 years as the National Preferred Partner of David Weekley Homes, and this six-year commitment is a natural next step for the two companies as they continue to work together to create value and efficiencies for builders and homeowners.

James Hardie, known for its signature Hardie® fiber cement siding and trim products designed to stand the test of time, has consistently set the industry standard for producing durable, affordable, and climate-resilient building solutions.

“This six-year agreement is truly an honor and the result of the shared goals between James Hardie and David Weekley Homes,” said Sean Gadd, President of James Hardie North America. “As many know we have been honored by David Weekley Homes in the past as their National Preferred Partner and are excited to continue this relationship together for many years to come.”

As an industry leader, James Hardie paves the way in creating superior and enduring home exterior products, empowering builders to offer long lasting homes to their customers. Hardie® products are world-renowned for the added benefit of trusted protection. Hardie® fiber cement products are noncombustible* and help provide protection against the elements, including severe weather.

“Our team at David Weekley Homes is extremely excited to continue building on the great foundation that we already have created with James Hardie with today’s announcement,” said John Schiegg, VP of Supply Chain Services for David Weekley Homes. “By this agreement we are not only committing to a relationship with James Hardie, but we are committing to the customers we serve by creating the best home building experience possible.”

For more information on Hardie® products, visit www.jameshardie.com.

*Hardie® siding complies with ASTM E136 as a noncombustible cladding. Noncombustible siding, when combined with other fire mitigation measures, can help harden a home against external fire.


James Hardie Building Products Inc.


James Hardie is the North American leader in fiber cement exterior design solutions. Hardie® products offer long lasting beauty and endless design possibilities with trusted protection and low maintenance. As the #1 producer of high-performance fiber cement building solutions in the United States, James Hardie offers siding and accessories for every style. Hardie® products are noncombustible and stand up to weather and time while empowering homeowners and building professionals to achieve the home of their dreams. James Hardie operates with an inclusive company culture and an unwavering commitment to Zero Harm. The company proudly employs a diverse workforce of over 3,700 employees in North America.

For more information and media resources, visit JamesHardie.com and JamesHardie.com/all-about-james-hardie/media-resources. For investor information, please visit ir.jameshardie.com.au.

Connect with James Hardie on social media:

Media Contact:
James Hardie
[email protected] 

Investor Contact:
Joe Ahlersmeyer, CFA
Vice President, Investor Relations
[email protected]


About David Weekley Homes

David Weekley Homes, founded in 1976, operates in 19 markets across the United States and is headquartered in Houston. David Weekley Homes was the first builder in the United States to be awarded the Triple Crown of American Home Building, an honor which includes “America’s Best Builder,” “National Housing Quality Award” and “National Builder of the Year.” Weekley Homes has been recognized 18 times by Great Place to Work® and Fortune magazine as one of the 100 Best Companies to Work For. Since inception, David Weekley Homes has closed more than 125,000 homes. For more information about David Weekley Homes, visit the company’s website at www.davidweekleyhomes.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/james-hardie-building-products-inc-locks-in-a-six-year-agreement-with-david-weekley-homes-302379200.html

SOURCE James Hardie Building Products Inc.

Posted on

Watts Water Technologies, Inc. Announces its Participation in the Gabelli 35th Annual Pump, Valve & Water Systems Symposium as well as the 2025 Northcoast Research Water Summit

Watts Water Technologies, Inc. Announces its Participation in the Gabelli 35th Annual Pump, Valve & Water Systems Symposium as well as the 2025 Northcoast Research Water Summit

NORTH ANDOVER, Mass.–(BUSINESS WIRE)–
Watts Water Technologies, Inc. (NYSE: WTS) today announced that Robert J. Pagano, Jr., Chief Executive Officer & President; Shashank Patel, Chief Financial Officer, and Diane McClintock, Senior Vice President FP&A and Investor Relations will virtually present and host 1×1 meetings in the Gabelli 35th Annual Pump, Valve & Water Systems Symposiumon Thursday, February 27, 2025 at 9:00 a.m. (Eastern Time). The presentation will be broadcast via webcast. The address of the webcast is Gabelli Funds 35th Annual Pump, Valve & Water Symposium – GAMCO Investors, Inc.

Watts Water Technologies, Inc. also announced today that Robert J. Pagano, Jr., Chief Executive Officer & President; Shashank Patel, Chief Financial Officer, and Diane McClintock, Senior Vice President FP&A and Investor Relations will participate in the 2025 Northcoast Research Water 1×1 Summit on Thursday, March 6, 2025, at 8:00 a.m. (London Local Time/GMT) at the Hilton London Olympia, 380 Kensington High Street, London, W14 8NL, United Kingdom.

Watts Water Technologies, Inc., through its family of companies, is a global manufacturer headquartered in the USA that provides one of the broadest plumbing, heating, and water quality product lines in the world. Watts Water companies and brands offer innovative plumbing, heating, and water quality solutions for commercial, residential, and industrial applications. For more information, visit www.watts.com.

Watts Water Technologies, Inc.

Diane McClintock

Senior Vice President FP&A and Investor Relations

Telephone: 978-689-6153

KEYWORDS: Europe United States United Kingdom North America Massachusetts

INDUSTRY KEYWORDS: Utilities Energy

MEDIA:

Logo
Logo
Posted on

Double Eagle IV Midco, LLC Enters Into Definitive Purchase Agreement With Diamondback Energy, Inc.

Double Eagle IV Midco, LLC Enters Into Definitive Purchase Agreement With Diamondback Energy, Inc.

— Diamondback Energy Acquires Certain Midland Basin Entities from Double Eagle —

FORT WORTH, Texas–(BUSINESS WIRE)–
Double Eagle IV Midco, LLC (“Double Eagle”) today announced that it has entered into a definitive purchase agreement to divest its equity interest in certain subsidiaries to Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”) in exchange for $3 billion of cash and approximately 6.9 million shares of Diamondback common stock.

Cody Campbell and John Sellers, Co-Chief Executive Officers of Double Eagle, commented “We are excited to announce our agreement with Diamondback. We believe our team has built a truly standout asset that further increases Diamondback’s high-quality inventory. It was important to us that we maintain the stewardship of this asset going forward not only with a world-class Midland operator but also a group that shares our core values and understands the importance of community impact in West Texas.”

Kyle Kafka, Partner of EnCap, added “We congratulate John, Cody and the entire Double Eagle team on another exceptional outcome and look forward to continuing our partnership. This high-quality asset base is a natural fit with Diamondback, the leading public operator in the Midland Basin, and we are excited to be a significant shareholder going forward.”

Timing and Approvals

Transaction is expected to close on April 1, 2025, subject to the satisfaction of customary closing conditions.

Advisors

RBC Capital Markets, Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC are acting as financial advisors to Double Eagle. Vinson & Elkins LLP is serving as legal advisor.

TPH&Co, the energy business of Perella Weinberg Partners, is serving as financial advisor to Diamondback. Kirkland & Ellis is acting as legal advisor to Diamondback.

About Double Eagle

Double Eagle IV Midco, LLC is an independent oil and natural gas company focused on development and production throughout the Permian Basin. Headquartered in Fort Worth, Texas, Double Eagle IV was formed in 2022 by the same management team that successfully led its predecessor companies. The Company was formed with equity capital commitments from EnCap Investments L.P., Apollo Natural Resources, Elda River Capital, Double Eagle Management, and other strategic institutional investors.

About EnCap Investments L.P.

Since 1988, EnCap Investments has been a leading provider of growth capital to the independent sector of the U.S. energy industry. The firm has raised 25 institutional funds totalling approximately $47 billion and currently manages capital on behalf of more than 350 U.S. and international investors. For more information, please visit www.encapinvestments.com.

For Double Eagle:

Jordan Huelse

Vice President – Finance

817-928-3260

[email protected]

For EnCap:

Meredith Hargrove Howard

Redbird Communications Group

210-737-4478

[email protected]

For other investor inquiries regarding EnCap:

Charles W. Bauer

Partner – Investor Relations

713-659-6100

[email protected]

Matt Crystal

Managing Director – Investor Relations

713-659-6100

[email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Oil/Gas Energy

MEDIA:

Logo
Logo
Posted on

ALAR Investors Have Opportunity to Lead Alarum Technologies Ltd. Securities Fraud Lawsuit

PR Newswire


NEW YORK
, Feb. 18, 2025 /PRNewswire/ — 

Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Alarum Technologies Ltd. (NASDAQ: ALAR) between March 14, 2024 and August 26, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 15, 2025.

So What: If you purchased Alarum securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Alarum class action, go to https://rosenlegal.com/submit-form/?case_id=35175 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 15, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) Alarum was less effective in retaining and/or expanding customer engagements than it had represented to investors; (2) the foregoing would impair Alarum’s ability to generate consistent revenue growth; (3) accordingly, Alarum’s business and/or financial prospects were overstated; and (4) as a result, Alarum’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Alarum class action, go to https://rosenlegal.com/submit-form/?case_id=35175 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alar-investors-have-opportunity-to-lead-alarum-technologies-ltd-securities-fraud-lawsuit-302379123.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Elastic N.V. (NYSE: ESTC); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) — A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired ELASTIC N.V. (NYSE: ESTC) (“Elastic” or the “Company”) securities between May 31, 2024 and August 29, 2024 (the “Class Period”), charging the Company and certain senior executives with violations of the federal securities laws (collectively, “Defendants”).  

Elastic investors have until April 14, 2025 to seek appointment as lead plaintiff of the Elastic class action lawsuit.


If you purchased or acquired Elastic securities between May 31, 2024 and August 29, 2024, and suffered substantial losses
, and you wish to obtain additional information or serve as lead plaintiff in this lawsuit, you may submit your information and contact us here: https://dicellolevitt.com/securities/elastic/.

You can also contact DiCello Levitt attorneys Brian O’Mara or Ruben Peña by calling (888) 287-9005 or emailing [email protected].   Those who inquire by email are encouraged to include their mailing address, telephone number, and the number of shares purchased.

No Class Has Been Certified.   Until a class is certified, you are not represented by counsel unless you retain one.   You may select counsel of your choice.

Case Allegations

Elastic is an American-Dutch software company that provides a platform for real-time search, observability, security, and generative artificial intelligence (“AI”).   The Company’s platform enables customers to find insights and drive AI and machine learning use cases from large amounts of data.

On May 30, 2024, Elastic issued a press release providing financial guidance for the Company’s fiscal year (“FY”) 2025, including revenue of $1.468 billion to $1.48 billion, representing 16% year-over-year growth at the midpoint.

The Elastic lawsuit alleges that Defendants issued materially false and misleading statements about the Company’s business, operations, and prospects during the Class Period.   Specifically, Defendants failed to disclose that: (i) Elastic had significantly transformed its sales operations, particularly with respect to its customer segments in the Americas; (ii) the alterations were likely to, and did, disrupt Elastic’s sales operations during the first quarter of FY 2025; (iii) consequently, Defendants had exaggerated the stability of Elastic’s sales operations; and (iv) as a result, Elastic would probably not meet its previously issued revenue guidance for FY 2025.

The truth emerged on August 29, 2024, when Defendants issued a press release announcing they were lowering Elastic’s FY 2025 revenue guidance to a range of $1.436 billion to $1.444 billion from a previously issued FY 2025 revenue guidance of $1.468 billion to $1.48 billion. In the press release, Defendants explained the reduction in FY 2025 guidance was because Elastic had experienced “a slower start to the year with the volume of customer commitments impacted by segmentation changes that we made at the beginning of the year, which are taking longer than expected to settle. We have been taking steps to address this, but it will impact our revenue this year.”

That same day, during an earnings call to discuss Elastic’s first quarter financial results for FY 2025, Defendants clarified the nature, scope, and timing of the “segmentation changes” that had affected Elastic’s FY 2025 revenue guidance. In particular, Defendants disclosed that they had “created more focus on selling into our largest accounts by reducing the number of accounts per sales rep and created distinct greenfield territories to focus on landing new customers, both in the enterprise and commercial segments”; that they had implemented these changes too suddenly and should have “stagger[ed]” and implemented them “a little more gradually”; that these changes had impacted “pretty much all [of] the [Company’s] teams” in the Americas; that they had “anticipated some degree of change associated with” or were aware of these changes when they issued their initial FY 2025 revenue guidance; and that they had implemented these changes before the start of the Class Period.

On this news, the price of Elastic’s ordinary shares fell by $27.45 per share, or 26.49%, to close at $76.19 per share on August 30, 2024.

About DiCello Levitt

At DiCello Levitt, we are dedicated to achieving justice for our clients through class action, business-to-business, public client, whistleblower, personal injury, civil and human rights, and mass tort litigation. Our lawyers are highly respected for their ability to litigate and win cases – whether by trial, settlement, or otherwise – for people who have suffered harm, global corporations that have sustained significant economic losses, and public clients seeking to protect their citizens’ rights and interests. Every day, we put our reputations – and our capital – on the line for our clients.

DiCello Levitt has achieved top recognition as Plaintiffs Firm of the Year and Trial Innovation Firm of the Year by the National Law Journal, in addition to its top-tier Chambers and Benchmark ratings. The New York Law Journal also recently recognized DiCello Levitt as a Distinguished Leader in trial innovation. For more information about the Firm, including recent trial victories and case resolutions, please visit www.dicellolevitt.com.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Media Contact

Amy Coker
4747 Executive Drive, Suite 240
San Diego, CA 92121
619-963-2426
[email protected]



Posted on

UBS Advisor Team The Matthews Group Named to Forbes Top Wealth Management Teams and Best-in-State Lists

UBS Advisor Team The Matthews Group Named to Forbes Top Wealth Management Teams and Best-in-State Lists

BELLEVUE, Wash.–(BUSINESS WIRE)–
UBS announced today that The Matthews Group, an advisor team based in the firm’s Bellevue office, has been named to the Forbes America’s Top Wealth Management Teams – Private Wealth 2024 list and the Best-In-State Wealth Management Teams 2025 list.

The 19-member team, led by Michael Matthews, Tyler Matthews, Melanie Matthews, Kathryn Sciba, Tanner Peelen, Kim Muska, Mandy Ho, Shawn Meeks, Renee Hawkes and Mike Bockner, have been entrusted with over $3 billion in client investable assets. Together, they provide a multi-disciplinary approach to delivering holistic advice to ultra-high net worth individuals, business owners, entrepreneurs and multi-generational families. The team is known for taking a detailed and highly customized approach to managing client portfolios, leveraging UBS’s global reach to help clients pursue what matters most to them.

“It is my pleasure to work with such an incredible group of professionals, and I am proud to see them recognized for their dedication to clients,” said Robert Giordano, Pacific Northwest Market Executive at UBS. “Clients rely on the team’s advice for a host of financial needs. They work closely together to offer the intimate and personal service you would expect from such a top-level team.”

The Forbes rankings, developed by SHOOK Research, are based on an algorithm of qualitative and quantitative data, including revenue trends, assets under management and compliance records. The Forbes Best-In-State Wealth Management Teams 2025 list features more than 5,300 teams with cumulative assets of $7 trillion. The Forbes America’s Top Wealth Management Teams Private Wealth list features 100 teams with cumulative assets of nearly $1.2 trillion.

For the full Best-In-State Wealth Management Teams list, visit: https://www.forbes.com/lists/wealth-management-teams-best-in-state/

For the full Top Wealth Management Teams Private Wealth list, visit: https://www.forbes.com/lists/top-wealth-management-teams-private-wealth/

Notes to Editors

About UBS

UBS is a leading and truly global wealth manager and the leading universal bank in Switzerland. It also provides diversified asset management solutions and focused investment banking capabilities. With the acquisition of Credit Suisse, UBS manages 5.7 trillion dollars of invested assets as per fourth quarter 2023. UBS helps clients achieve their financial goals through personalized advice, solutions and products. Headquartered in Zurich, Switzerland, the firm is operating in more than 50 markets around the globe. UBS Group shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).

© UBS 2025. All rights reserved. The key symbol and UBS are among the registered and unregistered trademarks of UBS. Although neither UBS Financial Services Inc. or its employees pay a fee in exchange for these ratings, UBS may hire RJ Shook to be a speaker for events. Past performance is not an indication of future results. For press use only.

Media Contact:

Christina Aquilina

[email protected]

https://www.ubs.com

KEYWORDS: United States North America Washington

INDUSTRY KEYWORDS: Professional Services Finance Consulting Asset Management Banking Personal Finance

MEDIA:

Logo
Logo
Posted on

BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit

PR Newswire


NEW YORK
, Feb. 18, 2025 /PRNewswire/ — 

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to the registration statement for BioAge’s initial public offering conducted on September 26, 2024 (the “IPO”), of the important March 10, 2025 lead plaintiff deadline.

So what: If you purchased BioAge stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the BioAge class action, go to https://rosenlegal.com/submit-form/?case_id=33167 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 10, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants touted its lead product candidate azelaprag in connection with BioAge’s ongoing STRIDES clinical trial with expectations of topline results in 2025. Defendants also mentioned its collaboration with Eli Lilly and Company’s (“Lilly”) Chorus clinical development organization who would be advising and assisting on all aspects of the STRIDES trial design and execution. Defendants further discussed the potential for a second Phase 2 clinical trial combining azelaprag and semaglutide to treat obesity in individuals ages 18 years and older. Therefore, the IPO represented to the public that there were no safety concerns and BioAge expected top line results and to meet its primary endpoint goals in connection with its STRIDES clinical trial.

Contrary to these representations, BioAge discontinued the ongoing STRIDES Phase 2 study of its investigational drug candidate azelaprag after several subjects showed elevated levels of liver enzymes warning of potential organ damage. As a result, defendants discontinued the clinical trial and halted further enrollment. Given the fact that defendants failure to disclose the potential for liver transaminitis in any of its previous clinical Phase 1 trials and various preclinical tox studies, defendants’ statements in BioAge’s registration statement were false and/or materially misleading at the time of the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the BioAge class action, go to https://rosenlegal.com/submit-form/?case_id=33167 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bioa-investors-have-opportunity-to-lead-bioage-labs-inc-securities-lawsuit-302379111.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit

PR Newswire


NEW YORK
, Feb. 18, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 14, 2025.

So what: If you purchased Merck securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Merck class action, go to https://rosenlegal.com/submit-form/?case_id=34975 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 14, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Details of the case: According to the lawsuit, throughout the Class Period, defendants provided investors with material information concerning Merck’s expected revenue of $11 billion from sales of Gardasil by 2030. Defendants’ statements included, among other things, confidence in Merck’s purported ability to utilize successful consumer activation and education efforts on the benefits of Gardasil in order to drive demand and capitalize on eligible populations for vaccination, resulting in confidently optimistic reports and forecasts of Gardasil’s growth in China. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Gardasil’s demand in China; notably, that Merck lacked visibility into demand for Gardasil in China among eligible and otherwise targeted populations, resulting in the inflated inventory of its distributor, Zhifei. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Merck class action, go to https://rosenlegal.com/submit-form/?case_id=34975 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/mrk-purchasers-have-opportunity-to-lead-merck–co-inc-securities-fraud-lawsuit-302379102.html

SOURCE THE ROSEN LAW FIRM, P. A.